Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...
Transcranial magnetic stimulation (TMS) has grown in popularity over the years as a treatment for patients with treatment-resistant depression, obsessive-compulsive disorder (OCD), and smoking ...
Transcranial magnetic stimulation (TMS) has proven to be a promising tool for research, diagnosis, and treatment of neurodegenerative diseases and psychiatric disorders such as depression, ...
Measuring changes in the characteristics of corticospinal output has become a critical part of assessing the impact of motor experience on cortical organization in both the intact and injured human ...